April 11, 2000
American Chemical Society
Scientists at Bristol-Myers Squibb have identified a promising new class of drugs that may yield strong candidates for the treatment of erectile dysfunction (also known as impotence) that may be more potent and have fewer side effects than the popular Viagra®, they say. The findings will appear in the April 6 print issue of the peer-reviewed Journal of Medicinal Chemistry, published by the American Chemical Society.
May Be More Potent, Have Fewer Side Effects Than Viagra®
The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.
Cite This Page:
American Chemical Society. "New Class Of Drugs For Erectile Dysfunction Unveiled." ScienceDaily. ScienceDaily, 11 April 2000. <www.sciencedaily.com/releases/2000/04/000410084314.htm>.
American Chemical Society. (2000, April 11). New Class Of Drugs For Erectile Dysfunction Unveiled. ScienceDaily. Retrieved March 8, 2014 from www.sciencedaily.com/releases/2000/04/000410084314.htm
American Chemical Society. "New Class Of Drugs For Erectile Dysfunction Unveiled." ScienceDaily. www.sciencedaily.com/releases/2000/04/000410084314.htm (accessed March 8, 2014).